Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BMEYE logo — Pioneering non-invasive cardiovascular monitoring with advan...

BMEYE

Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure and cardiac output technologies for global healthcare.

Founded 2005 Series B Total: $6.00M Biotechnology, Health Care +1

General Information

Company Name BMEYE
Founded Year 2005
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with BMEYE. To contact BMEYE, visit bmeye.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BMEYE compare?

A PDF of BMEYE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BMEYE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BMEYE

**BMEYE** is a Netherlands-based non-invasive cardiovascular monitoring company that has been pioneering advanced finger arterial pressure and cardiac output technologies for global healthcare since **2005**. The company's product offerings include **Finapres**, **Portapres**, **Finometer**, **BeatScope**, **Modelflow**, **Space instrumentation**, **Cardiopres**, **Oxyflow**, **Nexfin**, and **ccNexfin**, catering to various fields such as cardiology, anesthesiology, sleep observation, physiology, neurology, and internal medicine; and emergency, acute, intensive, and intermediate care. Additionally, it has received a notable **€6.00M Series B investment** from **360 Capital, Earlybird, LSP BioVentures, TechFund** on **08 October 2009**. With a focus on the research and development of medical technologies for cardiovascular monitoring, BMEYE has positioned itself as a promising player in the **Biotechnology, Health Care, and Medical Devices** industries. The company's headquarters is located in **Amsterdam, the Netherlands**. BMEYE's dedication to innovation in non-invasive monitoring technologies, backed by significant investment, positions it as a noteworthy venture in the healthcare sector.

Business keywords: cardiovascular monitoring, non-invasive monitoring, finger arterial pressure, cardiac output technologies, biomedical engineering, innovative medical devices, hemodynamics monitoring, cardiology technology, anesthesiology equipment, physiological measurement, global healthcare solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €6.00M 4
360 Capital Earlybird
360 Capital, Earlybird +2
08 Oct 2009
Series A Undisclosed 3
360 Capital
360 Capital, TechFund +1
01 Jan 2009
Series A Undisclosed 3
TIIN Capital Business Angels Technostarters
TIIN Capital, Business Angels Technostarters +1
21 Sep 2006

BMEYE Alternatives & Competitors

View All Alternatives
BMEYE vs
Finapres Medical Systems
Finapres Medical Systems The Netherlands

The leading technology for continuous non-invasive blood pressure measurement, autonomic testing and...

16 employees
Health Care, Medical Devices
BMEYE vs
SunTech
SunTech United States

Clinical-Grade Non-Invasive Blood Pressure Technology and Medical Devices

107 employees
Health Care, Manufacturing
BMEYE vs
Uscom
Uscom Australia

Practice-changing, non-invasive cardiovascular and pulmonary devices.

44 employees
Biotechnology, Health Care
View all alternatives

FAQ About BMEYE

Pioneering non-invasive cardiovascular monitoring with advanced finger arterial pressure and cardiac output technologies for global healthcare.
BMEYE was founded in 2005.
BMEYE operates in Biotechnology, Health Care and Medical Devices. Its work centres on cardiovascular monitoring, non-invasive monitoring, finger arterial pressure and cardiac output technologies.
BMEYE has completed 3 funding rounds, raising a total of $6.00M. The latest funding stage is Series B.
Top alternatives and competitors to BMEYE include Finapres Medical Systems, SunTech, Uscom, RTM Vital SIgns, Biobeat. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BMEYE and Finapres Medical Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BMEYE, https://bouncewatch.com/company/bmeye, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout